NIHR and UKRI move into new phase of COVID-19 research funding
The National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) have announced an evolution of their funding for COVID-19 research for tackling the acute phase of the pandemic. The NIHR-UKRI COVID-19 rapid response initiative was established in February with the aim of financially supporting research projects during the most pressing stages of the COVID-19 emergency. Research involved could produce outcomes within 12 months, guiding diagnosis and management of the disease as well as informing public health approaches taken by national and local leaders.
New applications to this funding call will finish on the 30th June 2020. The next call is in regards to ‘Recovery and Learning’ to support research proposals of up to 24 months duration surrounding the comprehension and management of health and social care consequences of COVID-19. The Medical Research Council (MRC) will concentrate on funding research into COVID-19 interventions, and the Economic and Social Research Council (ESRC) is continuing to accept social science-oriented proposals on health and social care which do not fit with the NIHR call scope. Individual grant durations under this scheme are 18 months.
Chair of the NIHR-UKRI Rapid Response Panel, Professor David Heymann said: “We look forward to the outcomes of these projects and our other awards contributing to the understanding, diagnosis, prevention and management of COVID-19, and to the results informing future clinical practice and public health.” A joint portfolio of research learnings and progress will also be disseminated by NIHR and UKRI.